More about our sector?

this is your place

Bigfinite Announces Additions to Executive Team

Bigfinite Announces Senior Leadership Additions

SAN FRANCISCO, CA – (May 13, 2020) – Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that Brian Sweeney, Lawrence Baisch and Glenn Griffin have been added to the leadership team.

CRO Brian SweeneyBrian Sweeney has been named Chief Revenue Officer and brings over 35 years of experience in senior executive roles in Sales, Customer Care and Operations across geographies and leading teams selling solutions using data analytics, CRM, information services and other B2B technology products and services to grow with both public and private companies. Previously, Sweeney served as Chief Revenue and Customer Officer at IHS Markit where he led a worldwide organization targeting global and interconnected capital-intensive industries including Energy, Chemical, Automotive and Aerospace and Defense. Before IHS, Sweeney held senior executive positions at HP Software, LexisNexis, Oracle, Siebel Systems and IBM.

Lawrence Baisch joins Bigfinite as the Chief Customer Success Officer. Baisch brings over twenty-five years of domestic and international business expertise in information technology and strategy to Bigfinite. He is a proven technology strategy and customer solution expert, having launched and scaled several companies and by being a thought leader in terms of digital transformation. He recently was Founder & CEO of Luminous Systems and prior was an Enterprise Architect for Salesforce Inc., leading engagements with some of the largest pharma and medical device companies in North America. Baisch has led global customer support and professional services with Precise Software, Encover Inc., Oracle Consulting and Wells Fargo.

SVP Alliances Glenn GriffinGlenn Griffin joins Bigfinite as the new Senior Vice President of Global Alliances. He brings multi-functional executive experience running Alliances, Business Development, and Channel Sales teams across the globe. Griffin has a strong history of driving sales acceleration and market expansion via partner ecosystems for SaaS based enterprise solutions. Previously, Glenn Griffin served as the Vice President of Partnerships at disruptive high growth companies such as Optimizely, DocuSign, and NetSuite. 

“Brian, Lawrence, and Glenn are world-class executives who have been at the forefront of technology innovation their entire careers,” said John Vitalie, CEO of Bigfinite. “They bring the right mix of executive experience, operational excellence and possess the integrity that will   help propel our growth and lead us to a new level of market leadership for Bigfinite. We are very fortunate to have them joining the leadership team at this critical juncture.”

About Bigfinite, Inc.

Bigfinite is a software provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and pharma 4.0 technologies focused on optimizing pharmaceutical and biotech companies. The Bigfinite analytics platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Bigfinite offers an intuitive way to gain meaningful operational intelligence with data by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity. Founded in 2014, the company is based in San Francisco, California and also has a European office in Barcelona, Spain.

Crystal Black

VP of Marketing

Bigfinite Announces Additions to Executive Team

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that Brian Sweeney, Lawrence Baisch and Glenn Griffin have been added to the leadership team.
Crystal Black VP of Marketing

AI Algorithm Qualification

Pharmaceuticals and Biotech companies have no doubt that Artificial Intelligence (AI) is here to stay. Nonetheless, the opportunities AI technology offers are developing at a slow pace in a rather conservative manufacturing industry, aimed at managing production risks under controls that are subject to strong regulations. Fear of change? Risk aversion? Likely not.
Jordi Guitart VP of Artificial Intelligence

Bigfinite Announces Senior Leadership Additions

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that John Vitalie has been named Chief Executive Officer (CEO) and has been elected to the Board of Directors. David Merino has been named Chief Financial Officer (CFO) of Bigfinite.

Why Biotech and Pharma Need GxP for their Digital Transformation Projects Now

Technological Enhancements with Principal Component Analysis Combined with Artificial Intelligence

Bigfinite Closes Series B Financing with Atlantic Bridge and Honeywell Ventures to Drive Disruption in Manufacturing Analytics

2019 Xavier University AI Summit Reflections – Two Industries Ready for Change

Now that the dust has settled from the Xavier University AI Summit and our team is back to business, we’ve had time to process some of the highlights and key takeaways from the exciting event.  In the past few years, there has been a significant increase in the implementation of digital technologies into various industries that subsequently impacted the way we live, travel, and do business.  From driverless cars to 24/7 customer support chatbots, innovation and technology continue to spiral upward and as we’ve entered the 4th industrial revolution, and healthcare + biopharma should be no exception.  The Xavier University AI Summit is a great event that brings together a range of relevant stakeholders with common focus on artificial intelligence (AI).

Bigfinite and NNE Partnership

Bigfinite and NNE announced a strategic partner program agreement to collaborate around accelerating digital transformation within manufacturing operations at the world's leading pharmaceutical and biotech manufacturers. 

Where are Pharma Companies in the Age of Artificial Intelligence?

They say good things come to those who wait; we say good things come to those who wait but only the things left by the visionaries before them.  The pharmaceutical industry has long been known to lag in the adoption of new technology due to strong regulations. Even though regulators have recently begun to open up to several new ‘big data’ or pharma 4.0 technologies - the question remains, if pharma companies are doing the same?  In 2016, the European Pharmacopoeia 9.0 in Chapter 5.21 announced that neural networks (NN) and support vector machines (SVM) are valid chemometric techniques for processing analytical data sets. 

Data Scientist 4.0 – Bridging the World of Manufacturing and Data

Since the announcement of the 4th Industrial Revolution in 2011, multitudes of emerging technologies have transpired around “Industry 4.0”. Technologies such as digital twins, Industrial Internet of Things (IIoT), and cyber-physical systems have come into the scene as core elements, providing the necessary ingredients for a paradigm shift in manufacturing. Technologies around predictive analytics and artificial intelligence are pioneering new approaches with many use cases including predictive maintenance, autonomous process optimization, and pattern recognition - used to identify potential failures in real-time. Because of this, data science is becoming an invaluable discipline for our industry in order to transform information into knowledge.